Venkatesan Thamizhiniyan, Park Eun-Jin, Choi Young-Woong, Lee Jennifer, Kim Young-Kyoon
a Department of Forest products and Biotechnology , College of Forest Science, Kookmin University , Seoul , South Korea.
Pharm Biol. 2017 Dec;55(1):837-846. doi: 10.1080/13880209.2017.1278778.
Ternstroemia gymnanthera Sprague (Theaceae) possesses various known pharmacological properties. However, its anti-inflammatory activity has not been reported.
The anti-inflammatory activity of Ternstroemia gymnanthera stem bark aqueous extract (TGSBE) was evaluated using LPS-stimulated RAW264.7 macrophages.
Cytotoxicity was assessed by MTT assay after 24 h with TGSBE (25-200 μg/mL). Further testing used TGSBE at 100 and 200 μg/mL. Griess and ELISA methods after 24 h with TGSBE determined NO and cytokine levels, respectively; then, mRNA levels (iNOS & cytokines) were analyzed by Quantitative-PCR after 12 h. NF-κB and MAPK were assessed by immunoblotting after TGSBE treatment for 12 h, followed by LPS for 30 min. Immunofluorescence assay was also performed for NF-κB. ROS and MMP, after 12 h with TGSBE, were determined by flow cytometry. The antioxidant potential of TGSBE was analyzed by ABTS assay. The Folin-Ciocalteu method determined the total phenolic content of TGSBE. LPS concentration was 0.5 μg/mL.
TGSBE at 200 μg/mL showed about 96.2% viability while suppressing the production of NO (88.99%), TNFα (24.38%), IL-6 (61.70%) and IL-1β (55.12%) and gene expression by 67.88, 45.24, 65.84, and 70.48%, respectively. TGSBE decreased ROS (79.26%) and improved MMP (48.01%); it inhibited translocation of NF-κB and MAPK activation. Radical scavenging activity was 50% at 402.17 μg/mL (ascorbic acid standard: 88.8 μg/mL). Total phenolic content was 240.9 mg GAE/g.
TGSBE suppresses the inflammatory response by inhibiting the NF-κB and MAPK cascades exhibiting therapeutic potential to treat inflammatory diseases associated with increased activation of macrophages.
厚皮红淡比(山茶科)具有多种已知的药理特性。然而,其抗炎活性尚未见报道。
使用脂多糖刺激的RAW264.7巨噬细胞评估厚皮红淡比茎皮水提取物(TGSBE)的抗炎活性。
用MTT法在24小时后评估TGSBE(25 - 200μg/mL)的细胞毒性。进一步测试使用100和200μg/mL的TGSBE。24小时后,分别用格里斯试剂法和酶联免疫吸附测定法测定TGSBE处理后的一氧化氮(NO)和细胞因子水平;然后,12小时后通过定量聚合酶链反应分析mRNA水平(诱导型一氧化氮合酶&细胞因子)。TGSBE处理12小时后,再用脂多糖处理30分钟,通过免疫印迹法评估核因子κB(NF-κB)和丝裂原活化蛋白激酶(MAPK)。还对NF-κB进行了免疫荧光测定。TGSBE处理12小时后,通过流式细胞术测定活性氧(ROS)和线粒体膜电位(MMP)。通过ABTS法分析TGSBE的抗氧化潜力。用福林 - 酚法测定TGSBE的总酚含量。脂多糖浓度为0.5μg/mL。
200μg/mL的TGSBE在抑制NO(88.99%)、肿瘤坏死因子α(TNFα,24.38%)、白细胞介素 - 6(IL - 6,61.70%)和白细胞介素 - 1β(IL - 1β,55.12%)产生以及基因表达方面,分别有67.88%、45.24%、65.84%和70.48%的抑制率,同时细胞活力约为96.2%。TGSBE可降低ROS(79.26%)并改善MMP(48.01%);它抑制NF-κB的易位和MAPK的激活。在402.17μg/mL时自由基清除活性为50%(抗坏血酸标准:88.8μg/mL)。总酚含量为240.9mg没食子酸当量/克。
TGSBE通过抑制NF-κB和MAPK级联反应来抑制炎症反应,显示出治疗与巨噬细胞激活增加相关的炎症性疾病的治疗潜力。